In this clinical academic position, he will continue his work on retinal gene therapy at the Centre for Ophthalmology, Tübingen.
Dominik has been involved in pre-clinical and clinical gene therapy programmes in Professor Robert MacLaren’s group as MRC Clinical Research Training Fellow since 2012.
Professor Dominik Fischer is principal investigator of the first clinical retinal gene therapy trials in Germany with his team at the Universty Eye Hospital Tübingen.